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Abstract
Background: Single nucleotide polymorphisms (SNPs) are the most frequent type of genetic variation in
the human genome, and are of interest for the study of susceptibility to and protection from diseases. The
haplotype at chromosome 19q13.2-3 encompassing the three SNPs ASE-1 G-21A, RAI IVS1 A4364G and
ERCC1 Asn118Asn have been associated with risk of breast cancer and lung cancer. Haplotype carriers are
defined as the homozygous carriers of RAI IVS1 A4364GA, ERCC1 Asn118AsnT and ASE-1 G-21AG. We
aimed to evaluate whether the three polymorphisms and the haplotype are associated to risk of colorectal
cancer, and investigated gene-environment associations between the polymorphisms and the haplotype
and smoking status at enrolment, smoking duration, average smoking intensity and alcohol consumption,
respectively, in relation to risk of colorectal cancer.
Methods: Associations between the three individual polymorphisms, the haplotype and risk of colorectal
cancer were examined, as well as gene-environment interaction, in a Danish case-cohort study including
405 cases and a comparison group of 810 persons. Incidence rate ratio (IRR) were estimated by the Cox
proportional hazards model stratified according to gender, and two-sided 95% confidence intervals (CI)
and p-values were calculated based on robust estimates of the variance-covariance matrix and Wald's test
of the Cox regression parameter.
Results: No consistent associations between the three individual polymorphisms, the haplotype and risk
of colorectal cancer were found. No statistically significant interactions between the genotypes and the
lifestyle exposures smoking or alcohol consumption were observed.
Conclusion: Our results suggest that the ASE-1 G-21A, RAI IVS1 A4364G and ERCC1 Asn118Asn
polymorphisms and the previously identified haplotype are not associated with risk of colorectal cancer.
We found no evidence of gene-environment interaction between the three polymorphisms and the
haplotype and smoking intensity and alcohol consumption, respectively, in relation to the risk of colorectal
cancer.
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SNPs in DNA repair genes have been associated to risk of
several types of cancer, reviewed in [1]. Combining of
neighbouring SNPs into haplotypes may increase the
association with disease. We have previously identified a
haplotype at chromosome 19q13.2-3 encompassing three
SNPs in the genes ERCC1 (excision repair cross comple-
mentary group1), ASE-1 (antisense ERCC1, alias
CD3EAP) and RAI (RelA-associated inhibitor, alias iASPP
or PPP1R13L), strongly associated with risk of post-men-
opausal breast cancer [2] and lung cancer [3,4], and a
recent Norwegian study has reported a possible associa-
tion with risk of colorectal cancer among women [5].
Thus, the haplotype seems to be involved in a mechanism
affecting various cancer forms. The previously identified
haplotype consists of three marker SNPs: RAI IVS1
A4364G, ERCC1 Asn118Asn and ASE-1 G-21A, of which
haplotype carriers are defined as the homozygous carriers
of RAI IVS1 A4364GA, ERCC1 Asn118AsnT and ASE-1 G-
21AG.
RAI encodes a specific inhibitor of the RelA subunit (p65)
in the NF-κB transcription factor [6], which participates in
inflammatory responses [7] and as an regulator of apop-
tosis [8]. The regulator function of NF-κB, as an inhibitor
or an activator of apoptosis, may depend on the ratio
between the two NF-κB subunits RelA and c-Rel: An over-
expression of RelA inhibits apoptosis, while an over-
expression of c-Rel enhances apoptosis [8]. Inhibition of
RAI synthesis has been shown to inhibit apoptosis [9]. In
human colorectal adenomas and adenocarcinomas a con-
stitutively increased expression of RelA/NF-κB protein
have been observed [10,11]. The increase was not detected
in healthy colorectal mucosa [10]. It was recently shown
that RAI expression is increased in both adenoma and
adenocarcinoma tissue compared to tissue from normal
colonic mucosa in the same person [12] indicating that
high RAI expression occurs very early in the malignant
transformation. However, contradictory results have been
published as to whether the increased expression levels
inhibit or promote apoptosis [9,13]. The polymorphisms
in ERCC1 and in particular RAI are strongly associated
with risk of basal cell carcinoma [14,15].
ERCC1 encodes a subunit of the nucleotide excision repair
(NER) complex, which is required for the incision step of
NER [16]. For colorectal and lung cancer patients the
mRNA levels and the expression of the ERCC1 protein are
associated with the response to platinum-based chemo-
therapeutic drugs with direct impact on cancer patient sur-
vival. The level of response may be related to the ERCC1
Asn118Asn polymorphism [17-19], and the ERCC1
C8092A polymorphism as well, for lung cancer patients
[20]. These epidemiological results are not entirely con-
sistent, but they may indicate that the polymorphism pre-
dicts DNA repair capacity.
ASE-1 encodes a nucleolar protein, and is positioned in an
anti-sense orientation to and overlaps with the gene for
ERCC1. It is possibly involved with the RNA polymerase I
transcription complex [21]. The exact role of ASE-1 and
whether the overlapping between ERCC1 and ASE-1 gene
has biological relevance are unknown.
In studies of Caucasians, the haplotype encompassing the
three SNPs: ERCC1 Asn118Asn, ASE-1 G-21A and RAI
IVS1 A4364G was strongly associated to risk of post-men-
opausal breast cancer [2] and lung cancer [3] among
women less than 55 years of age when diagnosed with
their first cancer. Female homozygous carriers of the hap-
lotype were at a 7.02-fold (CI: 1.88–26.18) higher risk of
lung cancer compared to female non-carriers of the
homozygous haplotype, while the haplotype was associ-
ated to risk of breast cancer with an RR of 9.50 (CI: 2.21–
40.79) among female homozygous carriers of the haplo-
type, compared to women not carrying the homozygous
haplotype. An association was not detected in the older
age groups (55–60 years and > 60 years when diagnosed
with breast cancer) [2].
The mechanisms underlying the possible association
between alcohol consumption and tobacco smoking and
risk of colorectal cancer are unknown. Smoking has con-
sistently been associated with increased risk for adeno-
mas/polyps in colon and rectum [22]. Following tobacco
smoking and intake of alcohol, DNA adducts are formed
by metabolites of the carcinogens polycyclic aromatic
hydrocarbons, aromatic amines, nitrosamines, and etha-
nol [23,24]. The adducts are not only located in airway tis-
sue or the upper gastrointestinal tract, but are also found
in e.g. white blood cells, bladder and cervical tissue [25-
27], indicating that systemic circulation of the carcinogens
takes place. Thus, DNA lesions following tobacco smok-
ing and alcohol consumption combined with a low DNA
repair capacity or deficiency of triggering apoptosis in
colonocytes may possibly lead to malignant transforma-
tion of the cells.
To our knowledge only two studies have been reported on
gene-environment interactions with the predefined hap-
lotype: A Norwegian case-control study on colorectal ade-
nomas and adenocarcinomas [5] and our prospective
case-cohort study on lung cancer [4]. No interaction was
observed between the haplotype and cigarette smoking
and intake of alcohol, respectively, in relation to risk of
colorectal adenomas or adenocarcinomas [5]. In the lung
cancer study, a stronger adverse association between
smoking and risk of lung cancer were observed among
women with a high smoking intensity (> 20 g tobacco/Page 2 of 8
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than among female non-carriers of the homozygous hap-
lotype with the same smoking intensity. An interaction
between alcohol consumption and the haplotype was also
found: Male carriers of the haplotype had a higher risk of
lung cancer, whereas no association was found among
men who were not carrying the homozygous haplotype.
In the present study, we hypothesized that female
homozygous carriers of the previously identified haplo-
type have higher risk of colorectal cancer compared to
individuals not carrying the homozygous haplotype, [5].
We expect that the haplotype or individual SNPs are
linked to a biologically effective polymorphism. RAI is an
obvious candidate gene, since it has been shown to be
required for induction of apoptosis [28], possibly through
interaction with the p53 gene [13]. Furthermore, we
hypothesized the haplotype to interact with environmen-
tal factors such as smoking and alcohol consumption, in
relation to risk of colorectal cancer as previously observed
for lung cancer.
Methods
In 1993–1997, a total of 160,725 individuals were invited
to participate in the Danish prospective "Diet, Cancer and
Health" (DCH) study, the inclusion criteria being age 50–
64 years, born in Denmark and with no prior cancer diag-
nosis at the time of inclusion. In total, 57,053 participants
accepted the invitation and were enrolled in the cohort
[28]. At enrolment detailed information on diet, smoking
habits, lifestyle, weight, height, reproduction, medical
treatment, and other socio-economic characteristics and
environmental exposures were collected. Moreover,
blood, urine, fat tissue and other biological material was
sampled and stored at -150°C. All participants gave
informed consent. DCH and the present sub-study were
approved by the Regional Ethical Committees on Human
Studies in Copenhagen and Aarhus and by the Danish
Data Protection Agency. Among the cohort members
included in this study, 405 incident cases of colorectal
cancer were identified, 184 women and 221 men, in the
files of the nationwide Danish Cancer Registry [29], diag-
nosed between 1994 and 2003. Within the cohort we
defined a sub-cohort consisting of 368 women and 442
men who were randomly selected. Cases and sub-cohort
were matched on gender. Blood samples were available
for 397 cases and 800 members of the sub-cohort. Infor-
mation on smoking habits and alcohol consumption
were available for all participants in the present study.
Characteristics of the cases and the sub-cohort are shown
in Table 1.
DNA was isolated from frozen blood samples as described
[30]. All genotypes were determined by endpoint reading
on a Sequence Detection System ABI 7500 (Applied Bio-
systems, Nærum, Denmark). The case-control status of
the samples was blinded when analysing the DNA in the
laboratory. Controls with known genotypes were
included in each run and repeated genotyping of a ran-
dom 10% subset yielded 100% identical genotypes.
Primers and probes for ERCC1 Asn118Asn (C/T) (rs
#3177700), ASE-1 G-21A (rs #967591) and RAI A4364G
(rs #1970764) genotyping were as previously described
[4,31].
Five µL reactions contained 100 nM of each probe, 900
nM primers, 20–50 ng DNA and 1x Mastermix (Applied
Biosystems, Nærum, Denmark). The polymorphisms
were analysed for 40 cycles at 15s at 94°C, and an elonga-
tion step performed at 62°C (ASE-1), 62°C (RAI) and
63°C (ERCC1) for 60s.
The ERCC1 Asn118Asn genotyping was unsuccessful for 7
samples, whereas 2 were unsuccessful for ASE-1 G-21A
genotyping, and 8 for RAI A4364G.
The data were sampled according to the case-cohort
design and the unweighted case-cohort approach was
used for analysis [32]. Incidence rate ratios (IRR) for
colorectal cancer were estimated by the Cox proportional
hazards model. All the analyses were stratified according
to gender. Age was the underlying time axis. The analyses
Table 1: Characteristics of the study population nested within the 
Danish cohort Diet, Cancer and Health.
Cases Sub-cohort
Totala 405 (100) 810 (100)
Gendera
Men 221 (55) 442 (54)
Women 184 (45) 368 (46)
Age at inclusionb 58 (51–64) 56 (50–63)
Age at diagnosisb 62 (54–70) -
Alcohol intake, g/dayb
Total 13 (1–69) 12 (1–63)
Men 23 (2–88) 19 (1–77)
Women 8 (0–41) 8 (1–39)
Smoking status at inclusiona
Never 123 (30) 272 (33)
Former 122 (30) 252 (31)
Present 160 (40) 286 (36)
Smoking intensity, g tobacco/dayb
Total 15 (4–37) 15 (2–35)
Men 19 (4–41) 18 (2–40)
Women 12 (3–22) 12 (2–23)
Smoking duration, yearsb
Total 34 (8–47) 32 (6–46)
Men 34 (8–48) 32 (8–48)
Women 34 (7–45) 32 (4–44)
a) Number (%)
b) Median (5–95% percentiles)Page 3 of 8
(page number not for citation purposes)
BMC Cancer 2008, 8:54 http://www.biomedcentral.com/1471-2407/8/54were corrected for delayed entry, thereby considering risk
only from the person's age at enrolment in the cohort. We
calculated two-sided 95% confidence intervals (CI) and p-
values based on robust estimates of the variance-covari-
ance matrix [33] and Wald's test of the Cox regression
parameter, that is, on the log rate ratio scale.
The genotype distributions of the polymorphisms were
checked among the sub-cohort to verify Hardy-Weinberg
equilibrium. We estimated IRR for the heterozygous and
the homozygous variant, respectively, compared with the
homozygous wild type. These estimates were supple-
mented with a trend test where the IRR is assumed to
increase/decrease log-linearly with the number of variant
type alleles. We analyzed data separately for each gender
and each of two age groups (≤ 60 years and > 60 years)
and separately according to topology of the cancer (colon
or rectum, right- or left-sided segment of colon).
Smoking intensity was calculated as the average of the
self-reported smoking intensity for the age intervals 20–
29, 30–39, 40–49 and 50–59 years and reported smoking
status, smoking duration and alcohol consumption refer
to the time of enrolment into the cohort study. Former
smokers were defined as the participants who have been
smoking regularly, at least one cigarette, pipe, cheroot or
cigar daily, for at least one year, but who were not smok-
ing daily at the time of enrolment. Smoking intensity for
former smokers were calculated as the smoking intensity
for each age intervals subtracted the periods of not smok-
ing.
For each of the continuous variables, the hypothesis of a
linear association was evaluated using a linear spline with
three boundaries, placed at the quartiles among cases, as
covariates in the Cox model [34]. The linearity was evalu-
ated graphically and by a numerical test using the likeli-
hood ratio test statistic to compare the model assuming
linearity with the linear spline model. All variables were
found linearly associated with colorectal cancer.
Interactions between the genotypes and each of the envi-
ronmental factors, smoking status, smoking duration,
average smoking intensity and alcohol consumption,
were analysed by estimating separate associations for each
genotype (homozygous wild type, heterozygous type and
homozygous variant type). We tested the null hypothesis
that the effect of the environmental factor was the same
for the three genotypes. All models on gene-environment
interactions were adjusted for smoking status (ever/never)
or alcohol intake (yes/no). Thus, the effect of smoking
intensity and duration were estimated among smokers
only, and the effect of alcohol intake was estimated
among alcohol consumers only. In the Cox regression
model, we stratified according to gender allowing separate
underlying risk for men and women, respectively. Hence,
adjustment for HRT use in the analyses affects the risk esti-
mates for women only. We used SAS PROC PHREG (ver-
sion 8.2) for the estimations.
An 80% power required IRRs between 1.3 and 1.4 per var-
iant allele for the three polymorphisms in the analyses of
a linear trend at a significance level of 5%. A similar power
required an IRR of 1.5 for the homozygous haplotype ver-
sus non-carriers of the homozygous haplotype. The power
calculations were made on the basis of the allele frequen-
cies and number of participants in the present study.
Results
Fifty-two percent of the cases were diagnosed with colon
cancer, 45% with rectal cancer, and in 3% of the cases the
topography was not specified. Among cases, 96% had a
diagnosis of adenocarcinomas, 2% of carcinoid tumor
and 2% of various other histological subtypes. The distri-
bution of cancer location was comparable for men and
women, data not shown. The median consumption of
alcohol was comparable between cases and sub-cohort
members (Table 1). The proportion of present smokers
was higher among cases than among members of the sub-
cohort. Smoking intensity was comparable between cases
and members of the sub-cohort, while smoking duration
among male and female cases, respectively, were longer
than among members of the sub-cohort. Smoking inten-
sity was substantially higher among men than among
women. In addition, the alcohol consumption was higher
among men than women (Table 1).
The genotype distributions were in Hardy-Weinberg equi-
librium among the sub-cohort members for all three pol-
ymorphisms both before and after gender separation,
results not shown. The allelic frequencies of the variant
allele for ASE-1 G-21A (0.17), RAI IVS1 A4364G (0.19),
and ERCC1 Asn118Asn (0.36) were similar to the fre-
quencies of alleles found in previous studies of Cauca-
sians [3,5,31]. The genotype distributions were
comparable between cases and members of the sub-
cohort, results not shown.
Overall, there were no statistically significant associations
between the three polymorphisms and risk of colorectal
cancer, either among men or women (Table 2). The asso-
ciation between the haplotype and risk of colorectal can-
cer did not differ statistically significant between men and
women (P = 0.16). However, women carrying the high
risk haplotype seemed to be at higher risk of colorectal
cancer with an IRR of 1.35 (0.84–2.16), compared with
female non-carriers of the homozygous haplotype. The
association between the three polymorphisms, ASE-1 G-
21A, RAI IVS1 A4364G and ERCC1 Asn118Asn and color-Page 4 of 8
(page number not for citation purposes)
BMC Cancer 2008, 8:54 http://www.biomedcentral.com/1471-2407/8/54ectal cancer was not statistically significant different (all P
> 0.25) between genders.
There were no significant effects of the three polymor-
phisms and the haplotype in relation to risk of colorectal
cancer in the topological sub-groups (left-or right sided
segment of colon or rectal, results not shown), and no sta-
tistically significant effects were observed of the three pol-
ymorphisms and the high risk haplotype in relation to
risk of colorectal cancer in either of the two age groups (≤
60 years and > 60 years), results not shown. Thus, further
statistical analysis includes all cases regardless of location
of the cancer and age when diagnosed with colorectal can-
cer. The effect of smoking status at enrolment, smoking
duration, average smoking intensity and intake of alcohol
on colorectal cancer risk did not differ between genders,
results not shown. However, since we previously have
found gender-specific gene-environment interactions in
the recent lung cancer study, the interaction studies on the
polymorphisms and the haplotype were stratified by gen-
der.
There were no statistically significant interactions between
the haplotype and smoking intensity or alcohol consump-
tion (Table 3), or between the ASE-1 G-21A, RAI IVS1
A4364G and ERCC1 Asn118Asn polymorphisms, respec-
tively, and smoking intensity or alcohol consumption
(see Additional file 1), in relation to risk of colorectal can-
cer. Yet, there was a tendency that smoking intensity was
a risk factor for colorectal cancer among homozygous car-
riers of the variant ASE-1 G-21A allele especially among
men. No effect was observed among carriers of the wild
type. We observed no statistically significant interactions
between the genotypes and smoking status and smoking
duration at enrolment associated to risk of colorectal can-
cer, results not shown.
Discussion
Overall, we observed no association between the previ-
ously identified haplotype and the RAI IVS1 A4364G,
ASE-1 G-21A and ERCC1 Asn118Asn polymorphisms and
risk of colorectal cancer. We did not find any interactions
between the genotypes or the haplotype and the lifestyle
exposures smoking intensity or alcohol consumption in
relation to risk of colorectal cancer.
The present study is population based. Selection bias is
unlikely because the sub-cohort used was selected as a
stratified random sample from the same cohort that gave
rise to the included colorectal cancer cases. The inclusion
of 405 cases and a comparison group of 810 individuals
provided a relatively high statistical power. For all partici-
pants, information on smoking habits and alcohol con-
sumption was obtained at enrolment before a cancer
Table 2: Association between ERCC1 Asn118Asn, ASE-1G-21A, RAI IVS1 A4364G polymorphism and haplotype and risk of colorectal 
cancer
Men Women
SNP N cases/sub-cohort IRRab CI (95%)c Pd N cases/sub-cohort IRRab CI (95%)c Pd
ERCC1 Asn118Asn TT 84/177 1e * 84/156 1e *
CT 100/193 1.04 0.72–1.50 0.66 66/156 0.78 0.51–1.19 0.48
CC 34/61 1.13 0.66–1.94 27/52 0.90 0.50–1.63
missing 3/11 7/4
ASE-1 G-21A GG 152/299 1e * 124/248 1e *
AG 60/124 0.94 0.64–1.38 0.73 45/106 0.85 0.55–1.32 0.96
AA 7/10 2.11 0.71–6.21 9/11 1.58 0.60–4.18
missing 2/9 6/3
RAI IVS1 A4364G AA 156/280 1e * 107/230 1e *
AG 56/138 0.69 0.47–1.03 0.13 61/124 1.17 0.77–1.80 0.20
GG 6/13 0.89 0.31–2.57 8/10 1.95 0.71–5.33
missing 3/11
High risk haplotype No 165/319 1e * 125/280 1e *
Yesf 53/110 1.01 0.68–1.51 51/82 1.35 0.84–2.16
missing 3/13 8/6
a) IRR: incidence rate ratio
b) Adjusted for average smoking intensity, intake of alcohol, fruits/vegetables, fish/poultry, red and processed meat, dietary fibres, BMI and 
hormone replacement therapy.
c) CI: 95% confidence interval
d) P: trend test
e) The genotype serves as reference category
f) Homozygous carriers of the haplotype compared to the rest. Homozygous carrier of the previously identified haplotype consisting of ERCC1 
Asn118AsnTT, ASE-1 G-21AGG and RAI IVS1 A4364GAAPage 5 of 8
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classification of these exposures between the cases and the
comparison group.
In previous studies the RAI IVS1 A4364G polymorphism
has been associated with a lower risk of basal cell carci-
noma, lung cancer and post-menopausal breast cancer
[2,3,15] among homozygous carriers of the variant allele.
The strongest association with risk of breast cancer or
basal cell carcinoma was observed among the youngest
individuals [2,14,15]. The RAI IVS1 A4364G polymor-
phism was not associated with risk of testicular cancer
[31]. Our results on the ASE-1 G-21A and ERCC1
Asn118Asn polymorphisms and risk of colorectal cancer
are comparable to other cancer studies, where no associa-
tions have been observed between the two polymor-
phisms and risk of basal cell carcinoma, post-menopausal
breast cancer and testicular cancer [2,31,35].
A tendency of higher risk for colorectal carcinoma, with an
OR of 2.19 (CI: 0.95–5.04), was observed among Norwe-
gian women carrying the homozygous haplotype com-
pared to women not carrying the homozygous haplotype
[5]. The results of the present study are comparable, with
an IRR of 1.35 (CI: 0.84–2.16). However, in neither of the
studies statistically significant gender-specific gene effects
of the haplotype were observed. Previous studies on
breast and lung cancer found a strong age dependent and
gender-specific effect of the haplotype on risk of cancer
[2,3]. A possible reason for not detecting any association
between the haplotype and risk of colorectal cancer in the
present study, may thus be due to the relatively high age
among cases (median 62 years) when diagnosed with
colorectal cancer. We were not able to estimate a risk asso-
ciation for the age-group younger than 55 years due to low
number of cases (8 cases carrying the homozygous haplo-
type). When data was stratified by age with members of
the youngest age group being less or equal to 60 years
when diagnosed with colorectal cancer, still no statisti-
cally significant associations between the haplotype and
risk of colorectal cancer were detected, results not shown.
Smoking intensity increased the risk of colorectal cancer
among homozygous carriers of the variant ASE-1 G-21A
polymorphism. The effect may very possibly be a chance
finding due to low numbers of cases and members of the
sub-cohort. Thus, no convincing statistical significant
interactions were observed between the three genotypes
and alcohol consumption or the smoking variables
related with risk of colorectal cancer.
We observed no interaction between the haplotype and
smoking intensity on risk of colorectal cancer. Our previ-
ous study on risk of lung cancer found a borderline signif-
icant interaction (P = 0.06) between high smoking
intensity (>20 g tobacco/day) and the haplotype related
with risk of lung cancer, with a 2.03-fold increased risk of
lung cancer per additional 5 g tobacco/day among women
carrying the haplotype, while no association were
observed among female non-carriers of the haplotype
with a similar smoking intensity [4]. Among women with
a lower smoking intensity (≤ 20 g tobacco/day) no effect
was observed of smoking intensity on risk of lung cancer
among carriers or non-carriers of the homozygous haplo-
type. In the present study it was not possible to access the
effect of a high smoking intensity among women due to a
lower smoking intensity among female cases. The findings
in the present study is thus similar to the above men-
tioned results in the lung cancer study [4] for women with
a comparable low smoking intensity.
Table 3: Gene-environment interaction stratified by gender. Haplotype-specific effects of average smoking intensity and consumption 
of alcohol on the risk of colorectal cancer
Haplotype Men Women
Carriera N cases/sub-cohort IRRb CI (95%)c Pd N cases/sub-cohort IRRb CI (95%)c Pd
Smoking intensitye (per 10 g tobacco/day) No 130/232 0.93 0.76–1.13 0.26 62/149 1.58 0.99–2.50 0.42
Yes 45/74 1.14 0.79–1.63 31/52 1.23 0.64–2.38
missing 3/8 4/4
Alcohol intakef (per 10 g/day) No 164/313 1.04 0.97–1.12 0.15 121/276 1.15 0.98–1.36 0.17
Yes 51/104 1.20 1.00–1.43 47/80 0.87 0.61–1.25
missing 3/13 7/6
a) Homozygous carriers of the haplotype compared to the rest. Homozygous carrier of the previously identified haplotype consisting of ERCC1 
Asn118AsnTT, ASE-1 G-21AGG and RAI IVS1 A4364GAA
b) IRR: incidence rate ratio
c) CI: 95% confidence interval
d) P: test for interaction
e) Risk estimates for ever smokers only. Adjusted for smoking status (present/former/never), intake of alcohol, fruits/vegetables, fish/poultry, red 
and processed meat, dietary fibres, BMI and hormone replacement therapy.
f) Risk estimates for alcohol consumers only. Adjusted for average smoking intensity, fruits/vegetables, fish/poultry, red and processed meat, dietary 
fibres, BMI and hormone replacement therapyPage 6 of 8
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ent effect on carriers and non-carriers of the homozygous
haplotype (P > 0.13) among men and women, respec-
tively, in relation to risk of colorectal cancer. However, we
detected an adverse effect of alcohol among male carriers
of the homozygous haplotype, with an IRR of 1.20 (CI:
1.00–1.43), per 10 g alcohol intake per day. In the Norwe-
gian study of colorectal cancer, the alcohol consumption
was lower among cases than in the present study, and
approximately 40% of the cases were abstainers [36]. No
interaction between the high risk haplotype and alcohol
intake on risk of colorectal adenomas and carcinomas was
observed [5]. In our recent lung cancer study, alcohol con-
sumption was associated with a 1.40-fold (CI: 1.13–1.74)
increased risk of lung cancer per 10 g alcohol intake per
day among male carriers of the homozygous haplotype
[4]. The effect of alcohol was significantly different
between carriers and non-carriers of the homozygous hap-
lotype (P = 0.003). Although a similar gene-environment
interaction seems not to exist for colorectal cancer, we
cannot exclude a weak tendency of interaction between
alcohol consumption and the homozygous high risk hap-
lotype among men.
Conclusion
Overall, the ASE-1 G-21A, RAI IVS1 A4364G and ERCC1
Asn118Asn polymorphisms and the previously identified
haplotype were not associated with risk of colorectal can-
cer. No statistically significant interactions were observed
between the high risk haplotype, the three polymor-
phisms and smoking intensity and alcohol consumption,
respectively, in relation to the risk of colorectal cancer.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
RDH isolated the DNA for analysis, genotyped the DNA
samples, made the data analysis and drafted the manu-
script
MS and ORN contributed with strategies for data analysis
AT and KO brought the idea of the "Diet, Cancer and
Health" study and organized it
HW and UV contributed with idea and design of the
present study
All authors contributed to interpretation of the results and
to the final manuscript.
Additional material
Acknowledgements
We thank Anne-Karin Jensen, Lourdes M. Pedersen and Yonit M. Bertelsen 
for excellent technical assistance. This study was supported by Danish 
Research Council (Grant number 2052-03-0016) and a scholarship from 
the Danish Graduate School in Public Health Science and from the Faculty 
of Medicine at University of Copenhagen.
References
1. Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair
genes and associations with cancer risk.  Cancer Epidemiol
Biomarkers Prev 2002, 11:1513-1530.
2. Nexo BA, Vogel U, Olsen A, Ketelsen T, Bukowy Z, Thomsen BL,
Wallin H, Overvad K, Tjonneland A: A specific haplotype of single
nucleotide polymorphisms on chromosome 19q13.2-3
encompassing the gene RAI is indicative of post-menopausal
breast cancer before age 55.  Carcinogenesis 2003, 24:899-904.
3. Vogel U, Laros I, Jacobsen NR, Thomsen BL, Bak H, Olsen A, Bukowy
Z, Wallin H, Overvad K, Tjonneland A, Nexo BA, Raaschou-Nielsen
O: Two regions in chromosome 19q13.2-3 are associated
with risk of lung cancer.  Mutat Res 2004, 546:65-74.
4. Vogel U, Sorensen M, Hansen RD, Tjonneland A, Overvad K, Wallin
H, Nexo BA, Raaschou-Nielsen O: Gene-environment interac-
tions between smoking and a haplotype of RAI, ASE-1 and
ERCC1 polymorphisms among women in relation to risk of
lung cancer in a population-based study.  Cancer Lett 2007,
247:159-165.
5. Skjelbred CF, Sabo M, Nexo BA, Wallin H, Hansteen IL, Vogel U,
Kure EH: Effects of polymorphisms in ERCC1, ASE-1 and RAI
on the risk of colorectal carcinomas and adenomas: A case
control study.  BMC Cancer 2006, 6:175.
6. Yang JP, Hori M, Sanda T, Okamoto T: Identification of a novel
inhibitor of nuclear factor-kappaB, RelA-associated inhibi-
tor.  J Biol Chem 1999, 274:15662-15670.
7. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff
MF, Karin M: IKKbeta links inflammation and tumorigenesis in
a mouse model of colitis-associated cancer.  Cell 2004,
118:285-296.
8. Chen X, Kandasamy K, Srivastava RK: Differential roles of RelA
(p65) and c-Rel subunits of nuclear factor kappa B in tumor
necrosis factor-related apoptosis-inducing ligand signaling.
Cancer Res 2003, 63:1059-1066.
9. Laska MJ, Strandbygard D, Kjeldgaard A, Mains M, Corydon TJ,
Memon AA, Sorensen BS, Vogel U, Jensen UB, Nexo BA: Expression
of the RAI gene is conducive to apoptosis: studies of induc-
tion and interference.  Exp Cell Res 2007, 313:2611-2621.
10. Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A,
Schmidt WE, Schmitz F: Increased expression of RelA/nuclear
factor-kappa B protein correlates with colorectal tumori-
genesis.  Oncology 2003, 65:37-45.
11. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G,
Moldawer LL, Copeland EM III, Mackay S: Nuclear factor-kappa B
is upregulated in colorectal cancer.  Surgery 2001, 130:363-369.
Additional File 1
Table 4 Gene-environment interaction stratified by gender. ERCC1 
Asn118Asn, ASE-1 G-21A and RAI IVS1 A4364G genotype-specific 
effects of average smoking intensity and consumption of alcohol on the risk 
of colorectal cancer. The table presents the genotypic distribution of the 
three polymorphisms in the ERCC1, ASE-1 and RAI genes for both cases 
and controls, and the incidence rate ratios of colorectal cancer risk associ-
ated with the three polymorphisms.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2407-8-54-S1.pdf]Page 7 of 8
(page number not for citation purposes)
BMC Cancer 2008, 8:54 http://www.biomedcentral.com/1471-2407/8/54Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
12. Saebo M, Skjelbred CF, Nexo BA, Wallin H, Hansteen IL, Vogel U,
Kure EH: Increased mRNA expression levels of ERCC1,
OGG1 and RAI in colorectal adenomas and carcinomas.
BMC Cancer 2006, 6:208.
13. Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK,
O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, Kuwabara PE,
Lu X: iASPP oncoprotein is a key inhibitor of p53 conserved
from worm to human.  Nat Genet 2003, 33:162-167.
14. Rockenbauer E, Bendixen MH, Bukowy Z, Yin J, Jacobsen NR, Heda-
yati M, Vogel U, Grossman L, Bolund L, Nexo BA: Association of
chromosome 19q13.2-3 haplotypes with basal cell carci-
noma: tentative delineation of an involved region using data
for single nucleotide polymorphisms in two cohorts.  Carcino-
genesis 2002, 23:1149-1153.
15. Yin J, Rockenbauer E, Hedayati M, Jacobsen NR, Vogel U, Grossman
L, Bolund L, Nexo BA: Multiple single nucleotide polymor-
phisms on human chromosome 19q13.2-3 associate with risk
of Basal cell carcinoma.  Cancer Epidemiol Biomarkers Prev 2002,
11:1449-1453.
16. de Laat WL, Jaspers NG, Hoeijmakers JH: Molecular mechanism
of nucleotide excision repair.  Genes Dev 1999, 13:768-785.
17. Viguier J, Boige V, Miquel C, Pocard M, Giraudeau B, Sabourin JC,
Ducreux M, Sarasin A, Praz F: ERCC1 codon 118 polymorphism
is a predictive factor for the tumor response to oxaliplatin/5-
fluorouracil combination chemotherapy in patients with
advanced colorectal cancer.  Clin Cancer Res 2005, 11:6212-6217.
18. Park DJ, Zhang W, Stoehlmacher J, Tsao-Wei D, Groshen S, Gil J, Yun
J, Sones E, Mallik N, Lenz HJ: ERCC1 gene polymorphism as a
predictor for clinical outcome in advanced colorectal cancer
patients treated with platinum-based chemotherapy.  Clin Adv
Hematol Oncol 2003, 1:162-166.
19. Ryu JS, Hong YC, Han HS, Lee JE, Kim S, Park YM, Kim YC, Hwang
TS: Association between polymorphisms of ERCC1 and XPD
and survival in non-small-cell lung cancer patients treated
with cisplatin combination chemotherapy.  Lung Cancer 2004,
44:311-316.
20. Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC,
Lynch TJ, Su L, Christiani DC: Excision repair cross-complemen-
tation group 1 polymorphism predicts overall survival in
advanced non-small cell lung cancer patients treated with
platinum-based chemotherapy.  Clin Cancer Res 2004,
10:4939-4943.
21. Whitehead CM, Winkfein RJ, Fritzler MJ, Rattner JB: ASE-1: a novel
protein of the fibrillar centres of the nucleolus and nucleolus
organizer region of mitotic chromosomes.  Chromosoma 1997,
106:493-502.
22. Schottenfeld D, Winawer SJ: Cancers of the large intestine.  In
Cancer Epidemiology and Prevention Volume 39. second edition. Edited
by: Schottenfeld D and J.F.Jr. F. New York, Oxford University Press;
1996:813-840. 
23. Hecht SS, Hoffmann D: Tobacco-specific nitrosamines, an
important group of carcinogens in tobacco and tobacco
smoke.  Carcinogenesis 1988, 9:875-884.
24. Brooks PJ, Theruvathu JA: DNA adducts from acetaldehyde:
implications for alcohol-related carcinogenesis.  Alcohol 2005,
35:187-193.
25. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffmann D, Wang
X, Waggoner S: Identification  of benzo[a]pyrene metabolites
in cervical mucus and DNA adducts in cervical tissues in
humans by gas chromatography-mass spectrometry.  Cancer
Lett 1999, 146:127-134.
26. Benhamou S, Laplanche A, Guillonneau B, Mejean A, Desgrandchamps
F, Schrameck C, Degieux V, Perin F: DNA adducts in normal blad-
der tissue and bladder cancer risk.  Mutagenesis 2003,
18:445-448.
27. Fang JL, Vaca CE: Detection of DNA adducts of acetaldehyde in
peripheral white blood cells of alcohol abusers.  Carcinogenesis
1997, 18:627-632.
28. Tjonneland A, Gronbaek M, Stripp C, Overvad K: Wine intake and
diet in a random sample of 48763 Danish men and women.
Am J Clin Nutr 1999, 69:49-54.
29. Storm HH, Michelsen EV, Clemmensen IH, Pihl J: The Danish Can-
cer Registry--history, content, quality and use.  Dan Med Bull
1997, 44:535-539.
30. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure
for extracting DNA from human nucleated cells.  Nucleic Acids
Res 1988, 16:1215.
31. Laska MJ, Nexo BA, Vistisen K, Poulsen HE, Loft S, Vogel U: Poly-
morphisms in RAI and in genes of nucleotide and base exci-
sion repair are not associated with risk of testicular cancer.
Cancer Lett 2005, 225:245-251.
32. Barlow WE, Ichikawa L, Rosner D, Izumi S: Analysis of case-cohort
designs.  J Clin Epidemiol 1999, 52:1165-1172.
33. Barlow WE: Robust variance estimation for the case-cohort
design.  Biometrics 1994, 50:1064-1072.
34. Greenland S: Dose-response and trend analysis in epidemiol-
ogy: alternatives to categorical analysis.  Epidemiology 1995,
6:356-365.
35. Vogel U, Olsen A, Wallin H, Overvad K, Tjonneland A, Nexo BA:
Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on
the risk of basal cell carcinoma among Caucasians after age
50.  Cancer Detect Prev 2005, 29:209-214.
36. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G: Life-
style-related risk factors and chemoprevention for colorec-
tal neoplasia: experience from the large-scale NORCCAP
screening trial.  Eur J Cancer Prev 2005, 14:373-379.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/8/54/prepubPage 8 of 8
(page number not for citation purposes)
